Investor's Business Daily on MSN
Dexcom Stock, Down 13%, Haunted By Its 'Surprisingly Cautious' Outlook
Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled.
Stocktwits on MSN
Dexcom Stock Plunges 13% After-Hours As Q3 Margin Pressures Eclipse Record Profit — Retail Sees ‘Buy The Dip’ Setup
Investors focused on Dexcom’s lower gross margin of 61.3%, down about 170 basis points year-over-year, despite record revenue ...
After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...
Dexcom has received clearance for the first over-the-counter (OTC) glucose sensor in the U.S. The Food and Drug Administration cleared the device, Stelo, for use by people 18 years and older who are ...
LONDON--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
The diabetes tech firm tailored its software to the 25 million people in the U.S. who have Type 2 diabetes and do not use insulin. The device is similar to existing prescription CGMs. Users pair the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback